1. A pilot study on reparixin, a CXCR1/2 antagonist, to assess safety and efficacy in attenuating ischaemia–reperfusion injury and inflammation after on-pump coronary artery bypass graft surgery. (10th March 2015) Authors: Opfermann, P; Derhaschnig, U; Felli, A; Wenisch, J; Santer, D; Zuckermann, A; Dworschak, M; Jilma, B; Steinlechner, B Journal: Clinical and experimental immunology Issue: Volume 180:Number 1(2015:Apr.) Page Start: 131 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Predictors of early renal dysfunction after heart transplantation: a report from the International Consortium on Primary Graft Dysfunction. (3rd October 2022) Authors: Guzman Bofarull, J; Han, J; Moayedi, Y; Truby, L K; Foroutan, F; Miller, R; Potena, L; Zuckermann, A; Chih, S; Farr, M; Hall, S; Ross, H J; Khush, K; Farrero, M Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗